Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
17-Jun-25 | Buy | Heather Preston | 324.00p | 11,389 | £36,900.36 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
17-Jun-25 | Buy | Heather Preston | 324.00p | 11,389 | £36,900.36 |
Notifier | Holding | Value* |
---|---|---|
Roch Doliveux | 309,808 | £1,358,508 |
Heather Preston | 29,687 | £130,178 |
Frank Mathias | 20,000 | £87,700 |
Namrata P Patel | 9,170 | £40,210 |
Dame Kay Davies | 1,000 | £4,385 |
Notifier** | Holding | Value* |
---|---|---|
Briarwood Chase Management LLC | 13,851,927 | £60,740,700 |
Novo Nordisk Foundation | 12,048,802 | £52,833,997 |
Institut Merieux SA | 11,510,481 | £50,473,459 |
Briarwood Chase Management LLC | 11,171,966 | £48,989,071 |
VULPES LIFE SCIENCES FUND | 8,447,390 | £37,041,805 |
Liontrust Asset Management | 6,078,799 | £26,655,534 |
M&G Plc | 5,872,847 | £25,752,434 |
Legal & General Group Plc | 5,760,126 | £25,258,152 |
HSBC Global Custody Nominee (UK) Ltd | 4,700,000 | £20,609,500 |
Ameriprise Financial, Inc. | 4,108,146 | £18,014,220 |
Columbia Threadneedle Investments (London) | 3,834,977 | £16,816,374 |
Canaccord Genuity Group Inc | 3,699,438 | £16,222,036 |
Hargreaves Lansdown Asset Management | 3,475,237 | £15,238,914 |
SERUM LIFE SCIENCES LTD | 3,382,950 | £14,834,236 |
Nine Ten Capital | 3,117,228 | £13,669,045 |
Lansdowne Partners (London) | 3,085,765 | £13,531,080 |
Mr. S Shah | 2,898,750 | £12,711,019 |
Artisan Partners | 2,620,800 | £11,492,208 |
Cubana Investments Limited | 2,506,000 | £10,988,810 |
Interactive Investor Sharedealing | 2,372,412 | £10,403,027 |
TDWaterhouse | 852,076 | £3,736,353 |
Self Trade Stockbrokers | 657,039 | £2,881,116 |
Currency | UK Pounds |
Share Price | 438.50p |
Change Today | -4.00p |
% Change | -0.90 % |
52 Week High | 464.50 |
52 Week Low | 232.50 |
Volume | 13,458 |
Shares Issued | 106.20m |
Market Cap | £465.69m |
Beta | 0.02 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
09:27 | 200 @ 437.50p |
09:15 | 903 @ 439.77p |
09:12 | 0 @ 440.50p |
09:11 | 8 @ 436.50p |
09:08 | 48 @ 438.50p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research